CompletedNCT00043472

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Studying Hereditary breast cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Sharon A Savage, M.D.
National Cancer Institute (NCI)
Enrollment
40 target
Eligibility
19-100 years · FEMALE
Timeline
2003

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00043472 on ClinicalTrials.gov

Other trials for Hereditary breast cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary breast cancer

← Back to all trials